Latest

Registers› Irish medicines

Medicines register · Ireland

Every medicine authorised for the Irish market

The Health Products Regulatory Authority's full list of authorised products — brand, active substance, licence holder, licence number and market status. Filter it, cite it, and take it away as a file.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,336 authorised products are in this register. Synced 20 Sep 2026, 17:51 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Advagraf 0.5 mg prolonged-release hard capsules EU/1/07/387/001-002

Tacrolimus

Astellas Pharma Europe BV

—

Advagraf 0.5 mg prolonged-release hard capsules EU/1/07/387/1-2

Tacrolimus

Astellas Pharma Europe BV

—

Advagraf 1 mg prolonged-release hard capsules EU/1/07/387/003-006

Tacrolimus

Astellas Pharma Europe BV

—

Advagraf 1 mg prolonged-release hard capsules EU/1/07/387/3-6

Tacrolimus

Astellas Pharma Europe BV

—

Advagraf 3 mg prolonged-release hard capsules EU/1/07/387/011-013

Tacrolimus

Astellas Pharma Europe BV

—

Advagraf 3 mg prolonged-release hard capsules EU/1/07/387/11-13

Tacrolimus

Astellas Pharma Europe BV

—

Advagraf 5 mg prolonged-release hard capsules EU/1/07/387/007-008

Tacrolimus

Astellas Pharma Europe BV

—

Advagraf 5 mg prolonged-release hard capsules EU/1/07/387/7-8

Tacrolimus

Astellas Pharma Europe BV

—

Betmiga 25 mg prolonged-release tablets EU/1/12/809/001-007

Mirabegron (ym178)

Astellas Pharma Europe BV

—

Betmiga 50 mg prolonged-release tablets EU/1/12/809/008-014

Mirabegron (ym178)

Astellas Pharma Europe BV

—

Betmiga 8 mg/ml Granules for prolonged-release oral suspension EU/1/12/809/019-020

Mirabegron

Astellas Pharma Europe B.V.

—

Evrenzo 100 mg Film-coated tablet EU/1/21/1574/004

Roxadustat

Astellas Pharma Europe B.V.

—

Evrenzo 150 mg Film-coated tablet EU/1/21/1574/005

Roxadustat

Astellas Pharma Europe B.V.

—

Evrenzo 20 mg Film-coated tablet EU/1/21/1574/001

Roxadustat

Astellas Pharma Europe B.V.

—

Evrenzo 50 mg Film-coated tablet EU/1/21/1574/002

Roxadustat

Astellas Pharma Europe B.V.

—

Evrenzo 70 mg Film-coated tablet EU/1/21/1574/003

Roxadustat

Astellas Pharma Europe B.V.

—

Modigraf 0.2 mg granules for oral suspension EU/1/09/523/001

Tacrolimus

Astellas Pharma Europe BV

—

Modigraf 1 mg granules for oral suspension EU/1/09/523/002

Tacrolimus

Astellas Pharma Europe BV

—

Omnexel®, 400 micrograms prolonged release tablets, film-coated PA1241/006/001

Tamsulosin hydrochloride

Astellas Pharma Co. Limited

Marketed

Padcev 20 mg Powder for concentrate for solution for infusion EU/1/21/1615/001

Enfortumab Vedotin

Astellas Pharma Europe B.V.

—

Padcev 30 mg Powder for concentrate for solution for infusion EU/1/21/1615/002

Enfortumab Vedotin

Astellas Pharma Europe B.V.

—

Prograf 0.5 mg hard capsules PA1241/014/001

Tacrolimus

Astellas Pharma Co. Limited

Marketed

Prograf 1 mg hard capsules PA1241/014/002

Tacrolimus

Astellas Pharma Co. Limited

Marketed

Prograf 5 mg hard capsules PA1241/014/003

Tacrolimus

Astellas Pharma Co. Limited

Marketed

Prograf 5 mg/ml concentrate for solution for infusion PA1241/014/004

Tacrolimus

Astellas Pharma Co. Limited

Marketed

Protopic 0.1% Ointment EU/1/02/202/003

Tacrolimus

Astellas Pharma GmbH

—

Veoza 45 mg film-coated tablets EU/1/23/1771/001-003

Fezolinetant

Astellas Pharma Europe B.V.

—

Vesitirim 1 mg/ml oral suspension PA1241/009/003

Solifenacin succinate

Astellas Pharma Co. Limited

Marketed

Vesitirim 10 mg film-coated tablets PA1241/009/002

Solifenacin succinate

Astellas Pharma Co. Limited

Marketed

Vesitirim 5 mg film-coated tablets PA1241/009/001

Solifenacin succinate

Astellas Pharma Co. Limited

Marketed

Vesomni 6 mg/0.4 mg modified-release tablets PA1241/016/001

Solifenacin succinate, Tamsulosin hydrochloride

Astellas Pharma Co. Limited

Marketed

Vyloy 100 mg powder for concentrate for solution for infusion. EU/1/24/1856/001-002

Zolbetuximab

Astellas Pharma Europe B.V.

—

Xospata 40 mg film-coated tablets EU/1/19/1399/001

Gilteritinib fumarate

Astellas Pharma Europe B.V.

—

Xtandi 40 mg film-coated tablets EU/1/13/846/002

Enzalutamide

Astellas Pharma Europe B.V.

—

Xtandi 40 mg soft capsules EU/1/13/846/001

Enzalutamide

Astellas Pharma Europe BV

—

Xtandi 80 mg film-coated tablets EU/1/13/846/003

Enzalutamide

Astellas Pharma Europe B.V.

—

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 28 September 2026. https://priyalifescience.com/medicines

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.